We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
The work was one of the first to identify skin lesions associated with SARS-CoV-2 infection in children at the beginning of the pandemic.
A study led by the Paediatric Infectious Diseases and Immunodeficiencies Unit of the Vall d'Hebron University Hospital and the Infection in Immunocompromised Pediatric Patients group at the Vall d'Hebron Research Institute (VHIR) has received the Anales de Pediatría award for being the most cited publication in 2020 and 2021 and that has contributed the most to the journal's impact index in the last two years. The article, written in collaboration with Dr. Maria Mercadal, from the Pediatric Hepatology and Liver Transplantation Unit; Dr. Esther Lera, from the Pediatric Emergency Unit; and Dr. Vicenç Garcia-Patos, from the Dermatology Department of the Vall d'Hebron University Hospital, describes two cases of children with COVID-19 who had skin lesions associated with the infection.
Since the beginning of the pandemic, it has been observed that children with COVID-19 are usually asymptomatic or have only mild symptoms. In June 2020, Vall d'Hebron was one of the first centers to describe and publish in a scientific journal two cases of infection-related skin involvement. Specifically, a 6-year-old boy with previous liver disease presented with a skin rash and a 2-month-old girl came to the emergency room with fever and urticaria. In both cases, the skin conditions resolved in less than a week without severity.
"We were one of the first centers to describe this type of affections, which were later observed in many children with COVID-19, especially in the first wave", explains Dr. Maria Espiau, pediatrician of the Paediatric Infectious Diseases and Immunodeficiencies Unit of the Vall d'Hebron University Hospital and the Infection in Immunocompromised Pediatric Patients group at VHIR. "It is important to know this symptomatology as part of the clinical picture of the disease, as it can be easily confused with other common childhood diseases. Publications such as ours provide information so that medical professionals can detect these conditions", says Dr. Miriam Morey, resident physician in the Paediatric Infectious Diseases and Immunodeficiencies Unit at Vall d'Hebron Hospital and first author of the paper.
The award granted to Vall d'Hebron will be used to facilitate the attendance of pediatric residents of the hospital to scientific congresses to encourage participation in research during their training.
Paediatric Infectious Diseases and Immunodeficiencies Unit,
Children's Hospital and Woman's Hospital
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to firstname.lastname@example.org, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.